文献速递关节外科运动医学

股骨头软骨损伤的骨软骨同种异体移植术结局:至少2年随访

Outcomes of Osteochondral Allograft Transplantation for Femoral Head Cartilage Lesions: Minimum 2-Year Follow-Up.
PubMed 文献 · J Arthroplasty · 2024-06-20

该回顾性研究纳入29例2008至2021年因股骨头局灶性骨软骨损伤行栓状骨软骨同种异体移植(OCA)的患者,平均随访6.6年。5年和10年移植物生存率分别为78.4%和62.7%,10例(34.5%)转为全髋关节置换术(THA);术前诊断为骨坏死(ON)者生存率显著低于其他诊断者(P=0.002),末次随访改良Harris髋关节评分(mHHS)显著改善(P<0.001)。作者认为OCA是年轻、活跃且关节畸形轻微患者的可行治疗选择,可能延缓关节炎进展和THA需求,但ON患者临床结局较差。

要点

  • 29例股骨头骨软骨损伤患者行OCA移植,5年生存率78.4%,10年62.7%。
  • 34.5%患者转为THA;术前诊断ON者10年生存率41.8%,显著低于其他诊断的85.7%(P=0.002)。
  • mHHS从术前48.9显著改善至末次随访77.4(P<0.001),69.0%患者mHHS≥70。

核心结论

  • 作者认为OCA移植是年轻、活跃且既有关节畸形轻微的股骨头骨软骨缺损患者的可行治疗选择。
  • 作者认为OCA可能延缓关节炎进展和THA需求。
  • 术前诊断为ON的患者临床结局较其他诊断者差。

研究设计与样本

  • 回顾性综述,纳入2008至2021年间因股骨头局灶性骨软骨损伤接受栓状OCA移植的29例患者。
  • 术前及每次随访时采用改良Harris髋关节评分(mHHS)进行临床评估,术后X线片评估移植物完整性和骨关节炎严重程度。
  • 采用Kaplan-Meier生存分析及95%置信区间(CI),终点为转为全髋关节置换术(THA)。
  • 最低随访2年,平均6.6年(范围0.6至13.7年)。

主要发现

  • 纳入患者的总体移植物生存率在5年时为78.4%(95%CI:62.9至93.9),在10年时为62.7%(95%CI:39.6至85.8)。
  • 10例患者(34.5%)转为THA。
  • 对数秩检验显示,术前诊断为骨坏死(ON)者与其他诊断者之间的生存率有显著差异(P=0.002)。
  • ON患者的10年生存率为41.8%(95%CI:4.8至78.8),非ON诊断者的10年生存率为85.7%(95%CI:59.8至100)。
  • 平均mHHS从术前48.9(范围19至84)显著改善至末次随访77.4(范围35至100)(P<0.001)。

关键数值与推荐

  • 5年移植物生存率78.4%(95%CI:62.9至93.9)。
  • 10年移植物生存率62.7%(95%CI:39.6至85.8)。
  • ON患者10年生存率41.8%(95%CI:4.8至78.8) vs 非ON诊断者85.7%(95%CI:59.8至100),对数秩检验P=0.002。
  • mHHS从术前48.9改善至末次随访77.4(P<0.001)。
  • mHHS≥70者20例(69.0%);Kellgren和Lawrence分级增加者7髋(26.9%)。

临床怎么用

  • 作者认为OCA移植是年轻、活跃且既有关节畸形轻微的股骨头骨软骨缺损患者的可行治疗选择。
  • 作者认为OCA可能延缓关节炎进展和THA需求。
  • 作者指出术前诊断为ON的患者临床结局较其他诊断者差。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The surgical management of large osteochondral lesions of the femoral head in young, active patients remains controversial. Fresh osteochondral allograft (OCA) transplantation can be a highly effective treatment for these lesions in some patients. This study investigated survivorship as well as clinical and radiographic outcomes after fresh OCA transplantation at a minimum 2-year follow-up (mean, 6.6 years; range, 0.6 to 13.7 years). METHODS: A retrospective review of 29 patients who underwent plug OCA transplantation for focal femoral head osteochondral lesions between 2008 and 2021 was performed. Patients were assessed clinically using the modified Harris Hip score (mHHS) preoperatively and at each follow-up visit. Postoperative radiographs were evaluated for graft integrity and osteoarthritis severity. Kaplan-Meier survivorship analyses with 95% confidence intervals (CIs) were performed for the endpoint of conversion to total hip arthroplasty (THA). RESULTS: Overall graft survivorship for included patients was 78.4% (95% CI: 62.9 to 93.9) and 62.7% (95% CI: 39.6 to 85.8) at 5 and 10 years, respectively. There were ten patients (34.5%) who underwent conversion to THA. There was a significant difference using the log-rank test between survival for patients who had a preoperative diagnosis of osteonecrosis (ON) versus those who had other diagnoses (P = .002). The ten-year survival for those who had ON was 41.8% (95% CI: 4.8 to 78.8), and the ten-year survival for diagnoses other than ON was 85.7% (95% CI: 59.8 to 100). The mean mHHS score improved significantly (P < .001) from 48.9 (19 to 84) preoperatively to 77.4 (35 to 100) at the final follow-up. There were twenty patients (69.0%) who had mHHS ≥ 70 at the latest follow-up. Arthritic progression, indicated by an increase in the Kellgren and Lawrence grade, occurred in 7 hips (26.9%). CONCLUSIONS: An OCA transplantation is a viable treatment option for osteochondral defects of the femoral head in young, active patients who have minimal preexisting joint deformity. It may delay the progression of arthritis and the need for THA. Patients who had a preoperative diagnosis of ON had worse clinical outcomes than those who had other diagnoses.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Daud A, Chaudhry F, Braunstein D, et al. Outcomes of Osteochondral Allograft Transplantation for Femoral Head Cartilage Lesions: Minimum 2-Year Follow-Up. J Arthroplasty. 2024. PMID: 38908537. doi:10.1016/j.arth.2024.06.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。